EdgarLookup
4

PRIMARY DOCUMENT

Company
GT Biopharma, Inc.
Filed
June 4, 2020
Period of Report
June 2, 2020
Accession Number
0000939798-20-000007
View Document ↗ View on SEC.gov ↗